Target Price | $79.45 |
Price | $50.24 |
Potential |
58.15%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target Bio-Techne Corporation 2026 .
The average Bio-Techne Corporation target price is $79.45.
This is
58.15%
register free of charge
$95.00
89.09%
register free of charge
$51.00
1.51%
register free of charge
|
|
A rating was issued by 18 analysts: 12 Analysts recommend Bio-Techne Corporation to buy, 6 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bio-Techne Corporation stock has an average upside potential 2026 of
58.15%
register free of charge
|
Jun '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 1.16 | 1.23 |
1.97% | 5.91% | |
EBITDA Margin | 31.47% | 34.51% |
7.79% | 9.66% | |
Net Margin | 14.31% | 14.15% |
41.49% | 1.09% |
13 Analysts have issued a sales forecast Bio-Techne Corporation 2025 . The average Bio-Techne Corporation sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Bio-Techne Corporation EBITDA forecast 2025. The average Bio-Techne Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Bio-Techne Corporation Analysts have issued a net profit forecast 2025. The average Bio-Techne Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Jun '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.05 | 1.10 |
40.34% | 4.76% | |
P/E | 45.67 | |
EV/Sales | 6.65 |
5 Analysts have issued a Bio-Techne Corporation forecast for earnings per share. The average Bio-Techne Corporation EPS is
This results in the following potential growth metrics and future valuations:
Bio-Techne Corporation...
Analyst | Rating | Action | Date |
---|---|---|---|
Keybanc |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
Keybanc |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
Evercore ISI Group |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
Baird |
Locked
➜
Locked
|
Locked | Feb 19 2025 |
Keybanc |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
Analyst Rating | Date |
---|---|
Locked
Keybanc:
Locked
➜
Locked
|
Apr 09 2025 |
Locked
Keybanc:
Locked
➜
Locked
|
Apr 08 2025 |
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Mar 18 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Mar 04 2025 |
Locked
Baird:
Locked
➜
Locked
|
Feb 19 2025 |
Locked
Keybanc:
Locked
➜
Locked
|
Feb 06 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Feb 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.